Niels C Riedemann Selected Research

Niels C Riedemann Research Topics

Disease

27	Sepsis (Septicemia) 04/2015 - 06/2002
5	Infections 01/2022 - 10/2012
4	COVID-19 06/2023 - 12/2020
4	Septic Shock (Toxic Shock Syndrome) 12/2022 - 01/2012
3	Critical Illness (Critically Ill) 06/2023 - 01/2012
3	Pneumonia (Pneumonitis) 12/2022 - 12/2020
3	Acute Lung Injury 03/2005 - 07/2002
2	Acute Kidney Injury (Acute Renal Failure) 12/2022 - 06/2011
2	Inflammation (Inflammations) 12/2020 - 07/2002
2	Lung Injury 02/2015 - 03/2005
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2022
1	Virus Diseases (Viral Diseases) 12/2022
1	Dyspnea (Shortness of Breath) 12/2020
1	Atypical Hemolytic Uremic Syndrome 01/2017
1	Glomerulonephritis 01/2017
1	Death (Near-Death Experience) 04/2015
1	Viral Pneumonia 02/2015
1	Pneumococcal Pneumonia 10/2012
1	Wounds and Injuries (Trauma) 10/2012
1	Hemorrhage 10/2012
1	Peritonitis 01/2012
1	Liver Diseases (Liver Disease) 01/2012
1	Cholestasis 01/2012
1	Pulmonary Edema 03/2005
1	Reperfusion Injury 02/2003

Drug/Important Bio-Agent (IBA)

7	Complement System Proteins (Complement)IBA 12/2020 - 01/2003
6	Anaphylatoxin C5a ReceptorIBA 02/2004 - 06/2002
4	vilobelimabIBA 06/2023 - 12/2020
4	Monoclonal AntibodiesIBA 06/2023 - 12/2020
4	AnaphylatoxinsIBA 06/2023 - 02/2015
4	CytokinesIBA 03/2011 - 01/2003
4	Interleukin-6 (Interleukin 6)IBA 05/2007 - 01/2003
3	Immunoglobulin G (IgG)IBA 06/2005 - 07/2002
3	Proteins (Proteins, Gene)FDA Link 03/2005 - 07/2002
3	Messenger RNA (mRNA)IBA 04/2004 - 07/2002
2	Complement C5a (Complement 5a)IBA 06/2023 - 10/2010
2	AntibodiesIBA 06/2023 - 06/2005
2	Antigen-Antibody Complex (Immune Complex)IBA 03/2005 - 07/2002
1	EnzymesIBA 01/2022
1	Oxygen (Dioxygen)IBA 12/2020
1	eculizumab FDA Link 01/2017
1	Vancomycin FDA LinkGeneric 08/2014
1	p38 Mitogen-Activated Protein KinasesIBA 10/2012
1	ProcalcitoninIBA 10/2012
1	Biomarkers (Surrogate Marker)IBA 10/2012
1	4-O-carboxymethylascochlorinIBA 01/2012
1	Taurodeoxycholic AcidIBA 01/2012
1	Chenodeoxycholic Acid (Chenix)FDA Link 01/2012
1	BilirubinIBA 01/2012
1	Bile Acids and Salts (Bile Acids)IBA 01/2012
1	AnionsIBA 01/2012
1	Neutralizing AntibodiesIBA 01/2012
1	Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link 06/2011
1	GelatinIBA 06/2011
1	Colloids (Colloid)IBA 06/2011
1	Starch (Cornstarch)IBA 06/2011
1	Complement C1q (C1q Complement)IBA 03/2011
1	Interleukin-8 (Interleukin 8)IBA 10/2010
1	Interleukin-10 (Interleukin 10)IBA 05/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2007
1	CXC ChemokinesIBA 07/2006
1	AlbuminsIBA 03/2005
1	Peroxidase (Myeloperoxidase)IBA 03/2005
1	Macrophage Migration-Inhibitory FactorsIBA 07/2004
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2004
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2004
1	LipopolysaccharidesIBA 12/2003
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2003
1	LigandsIBA 10/2003
1	NF-kappa B (NF-kB)IBA 08/2003
1	Protein CIBA 04/2003
1	LipidsIBA 10/2002
1	IntegrinsIBA 07/2002
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 07/2002
1	CaspasesIBA 06/2002
1	Annexin A5IBA 06/2002

Therapy/Procedure

14	Punctures 01/2012 - 06/2002
14	Ligation 01/2012 - 06/2002
6	Therapeutics 12/2022 - 08/2003
1	Artificial Respiration (Mechanical Ventilation) 12/2022
1	Terminal Care (Care, Terminal) 04/2015
1	Renal Replacement Therapy (Therapies, Renal Replacement) 08/2014
1	Laparotomy 10/2012
1	Drug Therapy (Chemotherapy) 01/2012
1	Resuscitation 06/2011
1	Fluid Therapy (Oral Rehydration Therapy) 06/2011